Rising Prevalence Of Chronic Diseases Pushes Growth Of The Stem Cell Therapy Market

Stem Cell Therapy Market Report 2021: COVID-19 Growth And Change To 2030

Stem Cell Therapy Global Market Report 2021: COVID-19 Growth And Change To 2030

The Business Research Company’s Stem Cell Therapy Global Market Report 2021: COVID-19 Growth And Change To 2030

LONDON, GREATER LONDON, UK, March 22, 2021 /EINPresswire.com/ — Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reports

The rising prevalence of chronic diseases contributed to the growth of the stem cell therapy market. Long working hours, limited physical activity, and unhealthy eating and drinking habits contribute to the prevalence of chronic diseases among people, thus driving the need for stem cell therapy. According to a United Nations article, by 2030, the proportion of global deaths due to chronic diseases is expected to increase to 70% of total deaths. The global burden of chronic diseases is expected to reach about 60%. This rising prevalence of chronic diseases is expected to drive the stem cell therapy market.

The global stem cell therapy market size is expected to grow from $8.62 billion in 2020 to $10.2 billion in 2021 at a compound annual growth rate (CAGR) of 18.3%. The stem cell therapy market growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The global stem cell market is expected to reach $20.87 billion in 2025 at a CAGR of 20%.

Read More On The Global Stem Cell Therapy Market Report:
https://www.thebusinessresearchcompany.com/report/stem-cell-therapy-market-global-report-2020-30-covid-19-growth-and-change

TBRC’s stem cell market overview report is segmented by type into allogeneic stem cell therapy, autologous stem cell therapy. It is also segmented by cell source into adult stem cells, induced pluripotent stem cells, embryonic stem cells, by application into musculoskeletal disorders, wounds and injuries, cancer, autoimmune disorders, others, and by end-user into hospitals, clinics.

Major players in the stem cell and regenerative therapy market are Anterogen, JCR Pharmaceuticals, Medipost, Osiris Therapeutics, Pharmicell, Astellas Pharma, Cellectis, Celyad, Novadip Biosciences, and Gamida Cell.

Stem Cell Therapy Global Market Report 2021: COVID-19 Growth And Change To 2030 is one of a series of new reports from The Business Research Company that provides stem cell therapy market overview, forecast stem cell therapy market size and growth for the whole market, stem cell therapy market segments, and geographies, stem cell therapy market trends, stem cell therapy market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request For A Sample Of The Global Stem Cell Therapy Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3399&type=smp

Here Is A List Of Similar Reports By The Business Research Company:

Cell Therapy Global Market Report 2021: COVID 19 Growth And Change to 2030
https://www.thebusinessresearchcompany.com/report/cell-therapy-market-global-report-2020-30-covid-19-growth-and-change

CAR-T Therapy Market – By Target Antigen (CD19 Therapy, CD22 Therapy, BCMA Therapy, Others), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Others), And By Region, Opportunities And Strategies – Global Forecast To 2030
https://www.thebusinessresearchcompany.com/report/car-t-therapy-market

Oncology Drugs Market – By Type (Blood Cancer, Breast Cancer, Lung Cancer, Prostate cancer, Colorectal Cancer, Cervical cancer, Kidney cancer, Gastric Cancer, Brain Tumor, Skin Cancer, Ovarian Cancer, Bladder Cancer, Pancreatic Cancer, Thyroid cancer, Others), By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy, Hormonal Therapy), By Distribution Channel (Retail Pharmacies/Drug Stores, Hospital Pharmacies, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded, Generic), And By Region, Opportunities And Strategies – Global Forecast To 2030
https://www.thebusinessresearchcompany.com/report/oncology-drugs-market

Orthobiologics Devices And Equipment Global Market Report 2021: COVID 19 Impact and Recovery to 2030
https://www.thebusinessresearchcompany.com/report/orthobiologics-devices-and-equipment-global-market-report

Interested to know more about The Business Research Company?
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology. TBRC excels in company, market, and consumer research.

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn

Leave a Reply

Your email address will not be published.